Michigan Medicine’s C.S. Mott Children’s Hospital experts make special sequencing tests routine in treating high risk pediatric brain tumors.

Oncologist N. Lynn Henry, M.D., Ph.D., explains what metastatic breast cancer is, who it affects and how it's treated.

The finding suggests a potential target in the metabolism that could slow or prevent breast cancer metastasis.

Michigan Medicine surgeons have designed a new drug delivery technology which could help with bone regeneration.

An ovarian cancer diagnosis gave one 26-year-old patient new perspectives on life and adventure.

Prostate cancer patients can now pursue healthy sex lives/sexual relationships after surgery

Three early-stage cancer drug projects receive pilot grants to help them advance from the bench toward the bedside.

An early clinical trial on pancreatic cancer research finds a Wee1 inhibitor, combined with radiation and gemcitabine, is safe and potentially effective in pancreatic cancer treatment.

Guitarist and bladder cancer survivor, Rendal Wall of Kalamazoo, continues to live a life surrounded by music after bladder removal surgery.

Researchers characterize three ways in which the gene FOXA1 mutates to trigger prostate cancer.

Cancer biologists and engineers collaborated on a device that could help predict the likelihood of breast cancer metastasis.

Michigan-led research presents a new way of uncovering predictive biomarkers when data from large randomized trials aren’t available.

When the surgical wound doesn’t heal right, it can send some patients back to the operating room. A new technique tested at U-M could help identify which patients are at highest risk.

How prayer and trust in his care team helped Gerald Dixon get through chemotherapy, radiation and surgery for stage 3 cancer.

The largest study of its kind finds societal factors and access to quality care, rather than genetics, underlies higher prostate cancer mortality rates for black men.